Integrative systems biology, transcriptomic profiling, and experimental validation reveal enterolactone as a multi-target inhibitor of metastatic signalling in triple-negative breast cancer
Open Access
- 8 August 2025
- journal article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 190, 118437
Abstract
No abstract availableKeywords
Funding Information
- Bharati Vidyapeeth
- Department of Biotechnology, Ministry of Science and Technology, India
This publication has 88 references indexed in Scilit:
- Temporal myc dynamics permit mitotic bypass, promoting polyploid phenotypesCancer Letters, 2025
- Circulating tumor cells with metastasis-initiating competence survive fluid shear stress during hematogenous dissemination through CXCR4-PI3K/AKT signalingCancer Letters, 2024
- Glioblastoma research on zebrafish xenograft models: a systematic reviewClinical and Translational Oncology, 2023
- The mRNA and protein levels of the glycolytic enzymes lactate dehydrogenase A (LDHA) and phosphofructokinase platelet (PFKP) are good predictors of survival time, recurrence, and risk of death in cervical cancer patientsCancer Medicine, 2023
- The evolving tumor microenvironment: From cancer initiation to metastatic outgrowthCancer Cell, 2023
- Targeting cancer signaling pathways by natural products: Exploring promising anti-cancer agentsBiomedicine & Pharmacotherapy, 2022
- Integrated genomic analysis of proteasome alterations across 11,057 patients with 33 cancer types: clinically relevant outcomes in framework of 3P medicineEPMA Journal, 2021
- Transcriptional Regulation of the Warburg Effect in Cancer by SIX1Cancer Cell, 2018
- Alterations of the spindle checkpoint pathway in clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomasInternational Journal of Cancer, 2015
- δ-Aminolevulinic acid-induced fluorescence unmasks biological intratumoral heterogeneity within histologically homogeneous areas of malignant gliomasActa Neurochirurgica, 2015